Biotech Marketplace ZAGENO Connects All Stakeholders - a 360° Approach
BOSTON and BERLIN, Jan. 03, 2018 (GLOBE NEWSWIRE) -- ZAGENO Inc. offers a dynamic and industry-leading ecosystem for online ordering in the life science sector. In today's cluttered and nontransparent e-commerce setting, digitally streamlining purchasing processes has become increasingly crucial for all stakeholders. ZAGENO provides useful information for scientists, a decrease in internal costs for procurement departments, and increased reach towards high-potential target audiences for biotechnology vendors.
Life Science Marketplace Connects Major Stakeholders
ZAGENO was founded with the vision to connect scientists, administrative departments, and vendors of biotechnology products through one single platform. ZAGENO enables scientists to order research materials through a comprehensive e-commerce platform comparable to other online shopping websites for consumer products. ZAGENO's co-founders David Pumberger, Florian Wegener, and Kilian Veer established a holistic solution to satisfy all relevant stakeholders. The core of the ZAGENO engine is to fulfill scientists' needs and facilitate their decision-making processes by covering all touchpoints necessary to complete an order online. With the resulting advanced customer experience, ZAGENO laid the foundation for the start-up's accelerated traction with leading life science institutions, academic research environments, and life science research companies.
360° Purchasing Decisions - Bundling Crucial Information
To arrive at well-informed conclusions during the purchasing process is not always easy for scientists. After all, to question the obvious, go the extra mile, and strive for new insights is a personality trait one needs for a successful career in research. To better understand what is crucial for success in this environment, we analyzed scientists' purchasing behavior and brought together three components necessary for a thriving, digital life science marketplace: Content, Community, and Commerce.
Content, Community, and Commerce in Life Science Research
For ZAGENO, content means compiling product specifications from vendors, enabling product comparisons across manufacturers, and enhancing product descriptions and specifications where needed. ZAGENO's expert biotech team curates product details using machine learning software to deliver the best results. Furthermore, a patent-pending "Scientific Score" tells customers how widely used a specific product is and, for example, how many times the product has appeared in peer-reviewed publications.
Globally Accessible High-Value Community Knowledge
Community translates into building a holistic resource for scientists where they can exchange thoughts about products, get support via ZAGENO's unique biotech expert live chat, and access high-quality scientific content available to everyone. Early in 2018, ZAGENO will launch an ISSN-registered peer-review journal (EUREKA! Methods) that will be different from the majority of existing journals in one major respect: access and publishing will be free of charge. This will open opportunities for life science researchers in emerging markets and to scientific and academic institutions that lack adequate funding. With the launch of EUREKA! Methods, the start-up is approaching its next milestone in becoming a global and growing authority in the fields of life science research.
The ZAGENO Ecosystem for Life Science Ordering Online
A new, interconnected biotechnology e-commerce experience is what ZAGENO represents. Every touchpoint combination between scientists, vendors, and procurement needs a thoughtful, specific set-up to work effectively. To optimize, streamline and automate processes, every possible connection was rigorously analyzed, and their resulting scenarios examined. In combination with profound industry insights, the findings helped formulate ZAGENO's dynamic, market-leading set-up. ZAGENO's approach enables smooth, logical integration with all IT systems commonly used in the biotech e-commerce sector and particularly procurement departments. Biotechnology vendors and companies benefit from ZAGENO's online platform by reaching potential customers during their decision-making and buying process. Biotech brands can utilize ZAGENO as an additional digital sales channel to increase their brand's reach in key markets across the USA and Europe, strengthen brand awareness, and promote a positive brand image.
From unconnected stakeholders to integrated biotech industry members
"The entire online process of information gathering, ordering, and order approving within the life science and biotechnology sector is lacking coherence and ease," says Kilian Veer, Chief Operating Officer at ZAGENO Inc. "Maverick ordering is the only method a majority of scientists and laboratories can use to purchase research materials online because there is no other option available helping scientists to make purchasing decisions and streamline administrative order processes," he continues. "With ZAGENO," says Kilian, "we offer an ecosystem to connect all stakeholders via one single platform enabling quick purchasing decisions as well as coherent order information and tracking."
About ZAGENO Inc.
Since its formation in 2015, ZAGENO Inc. has set new standards in the international biotech market. With the vision to offer an online marketplace connecting scientists, academic research institutes, and biotech manufacturers, ZAGENO is growing exponentially and represents a milestone for the digitization of science and research. World-renowned research facilities use ZAGENO for ordering lab equipment and for optimizing internal processes. The start-up employs 47 staff members in Boston (USA) and Berlin (Germany). These two locations were selected for their proximity to renowned institutions known for their research advancements and scientific breakthroughs. For more EUREKA-moments - Welcome to ZAGENO: https://zageno.com
VP Digital Growth
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/af5e50c1-2fda-4001-8a2e-eb84e7269a0b
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ZAGENO, Inc. via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Ant Financial Hosts Technology Conference in Silicon Valley20.1.2018 06:39 | Pressemelding
Conference featured global fintech leaders and showcased Ant Financial's capabilities across blockchain, AI, security, IoT and computing SANTA CLARA, Calif., Jan. 20, 2018 (GLOBE NEWSWIRE) -- Ant Financial today hosted the Ant Technology Exploration Conference (ATEC) in Silicon Valley, bringing together global partners and technology leaders to explore new innovations and technologies that further Ant Financial's mission of bringing the world equal opportunities. This was the first ATEC held outside of China, following the inaugural ATEC held in Hangzhou in October 2017. The conference featured a diverse range of speakers from academia and industry to better explore the future of fintech, including Turing Award winner and MIT Professor Silvio Micali; Partner and Director of blockchain-based global payment platform Ripple, Emi Yoshikawa; founder of prediction market Bodhi, Xiahong Lin; and Director of JPMorgan Chase's digital channels, Umar Farooq, among others. Ant Financial's Vice Pre
Equis and Global Infrastructure Partners Announce Closing of US$5.0 Billion Renewable Energy Generation Acquisition of Equis Energy19.1.2018 17:28 | Pressemelding
Singapore, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Equis Pte. Ltd (Equis) and Global Infrastructure Partners (GIP) announcedtoday the closing of the previously announced sale by Equis of 100% of the equity interest in Equis Energyto GIP and its co-investors, for an enterprise value of USD5.0 billion (including assumed liabilities of USD1.3bn). The net transaction consideration has been settled in cash. Headquartered in Singapore, Equis Energy is the largest renewable energy independent power producer(IPP) in the Asia-Pacific region (APAC), with more than 180 assets comprising 11,135MW in operation,construction and development across APAC including Australia, Japan, India, Indonesia, the Philippinesand Thailand. The transaction is the largest renewable energy generation acquisition in history and positions GIP as adominant renewable energy developer in the key OECD growth markets of Australia and Japan, as well asacross India and South-East Asia. About Equis Energy Equis Energy operates from
XBiotech Announces Presentation of Phase 2 Open Label Extension Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa19.1.2018 14:00 | Pressemelding
Open Label Extension Results, which Demonstrate Significant Improvements in HS Patients Previously Treated with Placebo, will be Presented at the 7th Conference of the European Hidradenitis Suppurativa Foundation (EHSF) AUSTIN, Texas, Jan. 19, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that results from an open label extension (OLE) phase of the randomized Phase 2 study evaluating XBiotech's True Human(TM) antibody, MABp1, as a treatment for Hidradenitis Suppurativa (HS), will be presented at the European Hidradenitis Suppurativa Foundation (EHSF) Conference occurring in Rotterdam Netherlands February 7-9th. The oral presentation titled, "An open-label extension study of MABp1 targeting interleukin-1alpha for hidradenitis suppurativa (HS)" will be given by Theodora Kanni, M.D., Ph.D., Attikon University Hospital in Athens Greece, on 8 February 2018 between 1:50 and 2:50pm local time. The findings being presented come from patients that had received placebo in
The Search for #AconfidentYou Role Models Kicks Off at the Xehar Fashion Fairies Conference19.1.2018 12:00 | Pressemelding
Expanding their Fashion Fairies Program, Xehar Teaches and Inspires Women Through Confidence EL SEGUNDO, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Today, the Xehar team announces the Xehar Fashion Fairies Conference, which takes place over three days in Los Angeles, January 19th-21st. The conference gathers aspiring fashionistas to celebrate self love, natural beauty, and learn what it takes inspire women to be more confident. With powerful keynotes, exciting breakout sessions, a fashion show and international networking opportunities, the conference is a unique blend that is new to the fashion industry. "We are searching for our 2018 Fashion Fairies who are serious about a career in fashion and want to inspire women worldwide," says Hadari Oshri, founder and CEO of Xehar. "Attendees will learn how to become one of our exclusive #AconfidentYou Fashion Fairies." Propelled by the successful launch of its existing influencer outreach, Xehar has now expanded their Fashion Fairies program t
Olympus Labs Partners with Leading Korean Fintech Company Metaps Plus19.1.2018 00:03 | Pressemelding
Gibraltar, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Olympus Labs is quickly becoming an emerging global leader in the cryptocurrency-based financial product space, and on the heels of a successful token sale, Olympus is partnering with Seoul-based corporation Metaps Plus, a leading Korean fintech company and mobile marketing platform developer. This news comes shortly after the company announced OKEx, as its official exchange for the company's token MOT. "This is an amazing partnership for us, as it will allow us to hit the Korean market in a big way. We will be able to tap directly into the tens of millions of users on the Metaps Plus platform, allowing users to access financial products created by Olympus," said Kai Chen, CEO of Olympus Labs. "This is a key milestone as it demonstrates that Olympus products can be integrated in third party platforms such as mobile apps, wallets, exchanges, and even physical atms and pos systems, allowing users throughout the world access to Olympus products
Forward Industries Acquires Intelligent Product Solutions18.1.2018 23:54 | Pressemelding
WEST PALM BEACH, Fla. and HAUPPAUGE, N.Y., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Forward Industries (NASDAQ:FORD) today announced the acquisition of Intelligent Product Solutions (IPS), an industry leading product design and development company based in Long Island, New York for a material consideration comprising of cash, equity, and contingent earn outs. IPS clients include leading brands in consumer electronics, medical devices, enterprise and security solution providers and Internet of Things connected solutions, including Google, Physio Control, PepsiCo, Motorola, ABInBev, Zebra and Charity Water. Commenting on the transaction, Terry Wise, CEO of Forward Industries remarked, "I am delighted and excited with the acquisition of IPS. The company is an excellent strategic fit for Forward Industries. Its expertise and strong track record in designing connected/IOT products and developing products such as the AdhereTech 'smart' pill bottle will significantly strengthen and contribute to For
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom